Cargando…
Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics
Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults and one of the most aggressive cancers in man. Despite technological advances in surgical management, combined regimens of radiotherapy with new generation chemotherapy, the median survival for these patients is 14.6 mon...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893101/ https://www.ncbi.nlm.nih.gov/pubmed/20515495 http://dx.doi.org/10.1186/1476-4598-9-135 |